CHELT Therapy cryotherapy uses dry cold air at 40°C while monitoring and controlling the patient's tissue temperature. It causes strong superficial and deep vasoconstriction that slows cell metabolism, generates intense reactive hyperemia and reduces the conduction speed of nerve fibers. These benefits enhance the anti-inflammatory action, bio stimulation and analgesic effect respectively.

CHELT Therapy also emits hot dry air with adjustable temperature between 35°C and 55°C. The air, penetrating deep into the tissues, causes intense vasodilation, while the tissue temperature is monitored and controlled. The result is deep muscle relaxation, increased joint mobility, enhanced tissue regeneration and pain reduction through inhibition of nociceptive signals.

CHELT Therapy generates thermal shocks of 95°C in less than I second with thermal control of the treated biological tissue and activates an intense vascular workout generated by the synergistic effect of cryotherapy and dry air thermotherapy. This vascular training accelerates the natural healing process, reduces pain sensations and enhances anti-inflammatory action.

Thanks to the adaptive phototherapy of Therapy it is possible to maximise the therapeutic performaces in patients with different physiopathological characteristics, managing acute and chronic pain, oedemas, injuries, sores and musculoskeletal disorders. This patented technology, already decisive in many applications, uses the other features of CHELT Therapy to provide an even wider and more advanced range of therapies.

Cold dry air at 40°C is the carrier of THEAL laser therapy and allows high energy doses to be delivered deep down. At a superficial level, such air induces vasoconstriction, facilitating the penetration of the laser beam down to the deepest tissues: it is thus possible to administer high energy doses that favor the biomodulation of biological tissues.